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Abstract
Purpose: Advanced radiotherapy delivery systems designed for high-dose, high-pre-
cision treatments often come equipped with high-definition multi-leaf collimators
(HD-MLC) aimed at more finely shaping radiation dose to the target. In this work,
we study the effect of a high definition MLC on spine stereotactic body radiation
therapy (SBRT) treatment plan quality and plan deliverability.
Methods and Materials: Seventeen spine SBRT cases were planned with VMAT
using a standard definition MLC (M120), HD-MLC, and HD-MLC with an added
objective to reduce monitor units (MU). M120 plans were converted into plans deliv-
erable on an HD-MLC using in-house software. Plan quality and plan deliverability as
measured by portal dosimetry were compared among the three types of plans.
Results: Only minor differences were noted in plan quality between the M120 and
HD-MLC plans. Plans generated with the HD-MLC tended to have better spinal
cord sparing (3% reduction in maximum cord dose). HD-MLC plans on average had
12% more MU and 55% greater modulation complexity as defined by an in-house
metric. HD-MLC plans also had significantly degraded deliverability. Of the VMAT
arcs measured, 94% had lower gamma passing metrics when using the HD-MLC.
Conclusion: Modest improvements in plan quality were noted when switching from
M120 to HD-MLC at the expense of significantly less accurate deliverability in some cases.
P A C S
87.55.Qr, 87.55.D-, 87.55.dk
K E Y WORD S
complexity, deliverability, HD-MLC, spine SBRT
1 | INTRODUCTION
The TrueBeam STx and the EDGE linear accelerator from Varian
Medical Systems (Palo Alto, CA, USA) are equipped with a number
of features designed to facilitate the high-precision, high-accuracy
radiation treatment of small targets near critical structures both
intra- and extracranially.1 One such feature is the high-definition
multileaf collimator (HD-MLC), which uses 32 central 2.5 mm-width
leaves and 28 outer 5 mm-width leaves on each MLC bank (widths
projected to isocenter). The HD-MLC provides essentially twice the
resolution along the axis perpendicular to the leaf travel compared
to the standard Varian Millennium MLC (M120) which uses 40 cen-
tral 5 mm-width leaves and 20 outer 10 mm-width leaves in each
bank.
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For inversely optimized treatment plans, the added resolution of
the HD-MLC theoretically increases the ability of the optimizer to
produce a highly conformal treatment plan, sparing organs at risk
(OARs) while providing adequate target coverage. However, this
potential increase in plan quality depends on the ability of the opti-
mizer to efficiently and effectively search the allowed solution space
and additionally is fundamentally limited by the physical properties
of the photon beam and MLC leaves.
Our department began using Varian’s EDGE linear accelerator for
stereotactic treatments in January of 2016. Two of the first treat-
ment types to be transferred almost exclusively to the EDGE were
spinal stereotactic body radiation therapy (SBRT) and spinal stereo-
tactic radiosurgery (SRS), both delivered with volumetric modulated
arc therapy (VMAT). The geometric complexity of these cases, often
with irregularly shaped target volumes that may include multiple ver-
tebral bodies and can circumscribe the spinal cord, makes them
excellent candidates for treatment on this specialized accelerator.2
With the transfer of these patients to the EDGE, a marked
increase in plan modulation was observed, visualized both in the
MLC-leaf trajectory sequence in the Eclipse treatment planning sys-
tem (TPS) as well as quantified by the number of monitor units (MU)
and our in-house VMAT complexity metric.3,4 We also observed a
sudden increase in plans failing patient-specific quality assurance
with the ArcCHECK (Sun Nuclear Corporation, Melbourne, FL, USA).
Because there is often very little extra time built into the work-
flow for hypofractionated spine treatments, a failing pretreatment
quality assurance measurement can lead to significant disruption in
the planned treatment course. The case may either be replanned,
which often leads to a delay (or multiple delays) in the patient start
date, or the treatment team may elect to proceed with the initial
treatment plan and accept the added degree of delivery uncertainty.
The goal of this work was to evaluate the change in plan quality and
delivery accuracy when switching from the M120 to HD-MLC, and
to test the effect of an added optimization objective aimed at reduc-
ing plan modulation on these quality indices.
2 | METHODS
For this study, 17 previously treated spine SBRT cases employing the
M120 were selected for study. A variety of sites (3 C-spine, 11 T-spine,
and 3 L-spine) were chosen with geometries representative of that typi-
cally seen in our clinic. To ensure consistency in planning and plan qual-
ity, all cases chosen were replanned by an expert dosimetrist using the
current clinical version of our treatment planning system, Eclipse ver-
sion 13.6. Each of the cases was inverse planned with VMAT with the
Photon Optimizer on a fine (1.25 mm) grid using 2 arcs per our institu-
tional standard for spine SBRT. The final dose calculation was done on a
1 mm grid with Analytical Anisotropic Algorithm (AAA) version 13.6.23.
All plans had a prescription dose of 30 Gy delivered in three fractions
and used 6 MV-only beams. All plans were reviewed by a physicist and
physician with experience in spine SBRT. Once an acceptable plan was
generated (henceforth referred to as the M120 plan), for each case,
three additional versions of the plan were created, as shown in Table 1.
Consistent geometry was used across all plans within a given case (i.e.,
identical arc rotation length, collimator angles and jaw positions).
The M120(HD) plan was created by converting the M120 plan to
HD-MLC by grouping pairs of leaves to identically match the original MLC
pattern, and then adjusting the MLC positions outwards (making larger
apertures) by 0.7 mm to account for the fact that the dosimetric leaf gap
(DLG) for the HD-MLC is smaller compared to the M120.5 The adjust-
ment amount was chosen empirically by comparing the doses in the
M120 plan to the M120(HD) plan. Edits to the MLC positions were per-
formed using an in-house Matlab script (Mathworks, Natick, MA, USA).
The HD plan was created by reoptimizing the M120 plan with
the HD-MLC, using identical optimization objectives. The HD(MU)
plan was the same as the HD plan but had an added MU objective
(a penalty on an MU value above a given threshold) to reduce the
MU down to that of the M120 plan.
To evaluate plan quality and modulation complexity, the M120
plan was compared to the HD and HD(MU) plans. To evaluate deliv-
ery accuracy, we compared the M120(HD) plan to the HD and
HD(MU) plans. This approach was taken so that in terms of deliver-
ability, all plans could be compared on an equal footing: using the
same beam model, calculation algorithm, and delivery and measure-
ment system. This excluded any potential differences in the accuracy
of each workflow step for the M120 MLC versus the HD-MLC from
biasing our results. Additionally, with this approach, small deviations
in the dose distribution due to changing MLCs (i.e., converting M120
to M120(HD)) had no impact on the results of the study.
To quantify plan quality, several metrics for the target and nearby
OARs were used. Conformity index (CI) and gradient index (GI) were
used to quantify dose coverage and falloff between the three types of
plans. The conformity index used here was the Paddick index, given by:
CI ¼ TV
2
PI
PIV  TV (1)
where TVPI is the target volume encompassed by the prescription
isodose surface, PIV is the prescription isodose surface volume, and
TV is the target volume.
The gradient index was defined as
GI ¼ PI50%
PIV
(2)
where PI50% is the volume encompassed by the 50% dose isodose
surface. 6
TAB L E 1 Description of plans used in this study.
Plan name Description
M120 Original plan using M120 MLC
M120(HD) M120 plan recreated with HD-MLC by pairing the
MLC leaves
HD M120 plan reoptimized with identical objectives
on HD-MLC
HD(MU) HD plan reoptimized with MU objective to reduce
MU to that of the M120 plan
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To quantify plan complexity, we used a complexity metric devel-
oped in-house that analyzes an MU-weighted average of the leaf-
side perimeter divided by the aperture area.3 This metric was
designed to quantify plan modulation independent of target size,
plan dose, arc length, and MLC type, and is defined as,
M ¼ 1
MU
XN
i¼1
MUi  yiAi; (3)
where the sum is over all control point apertures from i = 1 to N,
MU is the total number of MU in the plan, MUi is the number of MU
delivered through aperture i, Ai is the open area of aperture i, and yi
is the aperture perimeter excluding the MLC leaf tips.
Our portal dosimetry measurements used the digital megavoltage
imager (DMI) on the EDGE linear accelerator and the portal dosimetry
application within Eclipse. This DMI was clinically commissioned for
6 MV photons with the Portal Dosimetry Image Prediction (PDIP) algo-
rithm version 13.6.23. For the dose comparisons in this study, we used
a locally normalized gamma analysis with 10% dose threshold and no
region of interest. Local normalization was used to help highlight poten-
tial differences in the deliverability between plans. All measurements
were autoaligned to the predicted image by the portal dosimetry soft-
ware, and our clinical agreement criteria of 4%/1 mm were applied.
In all cases shown below, statistical significance in the comparison
between plans was determined using the two-tailed Student’s t-test.
3 | RESULTS
Figures 1 and 2 illustrate the differences in the MU and modulation
complexity for the three types of plans used in this study (M120, HD,
and HD(MU)). The cases are sorted by the MU of the M120 plan. One
case (case 12) did not have an HD(MU) plan because the MU of the
HD plan was already lower than that of the M120 plan.
In the majority of cases, the MU-objective in the optimizer was able
to reduce theMU in theHD(MU) plan down to that of the originalM120
plan. The maximum value that can be used in the MU objective is 4000.
There were three cases where the M120 plan had MU >4000, which
resulted in the HD(MU) plan having fewer MU than the M120 plan (see
the left-most three cases in Fig. 1). The modulation complexity of the
HD plan was consistently higher than the corresponding M120 plan.
Using the MU objective slightly reduced the modulation complexity in
all but one case (case 3), but not to the level of theM120 plan.
Table 2 summarizes the data of Figs. 1 and 2. Both the MU and
the modulation complexity increased significantly between the M120
and the HD plans. The added MU objective reduced both the MU
and the complexity, but these values were still significantly higher
than those for the M120 plans.
Table 3 compares dosimetric parameters for the 17 test cases.
Some of the comparisons are statistically significantly different, but
the absolute difference may not be clinically relevant. The average
gradient index in the HD plans was 0.19 lower than in the M120
plans. Figure 3 illustrates the potential difference in dose distribu-
tions for this magnitude of change in GI. There is no clear best type
of plan according to these metrics.
Figure 4 shows an example portal dosimetry measurement. Only
the predicted images for the M120 plan are shown. The passing per-
centage is obtained by computing the number of passing measure-
ment points within the outlined area (defined by a 10% dose
threshold). Local analysis can cause exaggerated failures in low dose
regions; these points are not included in the pass rate percentage.
Figure 5 and Table 4 show the results of the portal dosimetry
analysis for the M120(HD), HD, and HD(MU) plans. These results are
per arc (two arcs per plan). For 2 arcs out of the 34 measured, the
HD and HD(MU) plans had higher passing rates than the correspond-
ing M120(HD) plan. For one arc, the M120(HD) plan was better than
HD but worse than the HD(MU). For all other arcs, the M120(HD)
outperformed the other two. All average passing rates were statisti-
cally significantly different from each other. For the portal dosimetry
measurements, gamma analysis with local normalization was used to
avoid artificially raising the passing rates for highly modulated plans.
Average global normalization passing rates for the 51 measured
plans are also included in Table 4 for reference.
4 | DISCUSSION
4.A | Plan quality
Plans generated with the HD-MLC tend to have better spinal cord
sparing (about 3% of cord max dose) than the M120 plans,
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however, dose falloff and conformity were only marginally better
when using the HD-MLC. Though some of the differences are sta-
tistically significant, they may not be clinically relevant. The MU
and complexity score both increased dramatically in order to
achieve these modest gains, and using the MU objective was not
effective in reducing the complexity though it worked well to
reduce the MU to the desired range. We note that the program-
ming of the MU objective was adjusted in version 13.6 of Eclipse
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F I G . 2 . Comparison of modulation
complexity for the M120, HD, and HD-MU
plans. The data are ordered identically to
Fig. 1.
TAB L E 2 Average MU and Complexity values for the 17 test cases.
M120 HD HD(MU)
P-value
M120 vs HD M120 vs HD(MU) HD vs HD(MU)
Average MU 3370  585 3783  613 3315  507 <0.001 0.07 <0.001
Average Complexity (mm1) 0.18  0.02 0.28  0.03 0.25  0.03 <0.001 <0.001 <0.001
TAB L E 3 Plan quality parameters of M120 and HD-MLC plans.
Quality Metric M120 HD HD(MU)
P-Value
M120 vs HD M120 vs HD(MU) HD vs HD(MU)
CI 0.72  0.10 0.74  0.10 0.73  0.10 0.01 0.003 0.17
GI 5.08  0.96 4.88  0.96 4.86  0.91 0.01 <0.001 0.43
PTV D98 (Gy) 22.7  5.1 22.3  5.3 22.7  5.1 0.02 0.96 0.01
PTV D90 (Gy) 28.6  3.0 28.6  2.9 28.5  3.0 0.56 0.10 0.40
Spinal Cord 0.1 cc (Gy) 16.6  1.1 16.1  0.9 16.5  0.9 0.01 0.69 0.01
(a) (b)
F I G . 3 . Comparison of two plans with
differing gradient indices. The plan on the
left (a) has a gradient index of 5.23 and
the plan on the right (b) has a gradient
index of 5.01. The color wash ends at 50%
of the prescription dose.
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and users of earlier versions may not reproduce the same results
as seen here.
4.B | Deliverability
Portal dosimetry measurements show that the spine plans optimized
with the HD-MLC have significantly degraded deliverability. Using
global normalization (last row of Table 4), the passing rates of the
plans generated for this study were very similar to the passing rates
we observed with clinical plans prior to the initiation of this study.
Using local normalization, over two-thirds of the measured HD plans
fell below a 95% pass rate threshold. The deliverability was some-
what improved with the added MU objective, but did not match that
of the original M120 plan. This was expected as though the MU
were lower for the HD(MU) plans, the modulation complexity scores
were still high compared to the M120 plans. We note that all plans
F I G . 4 . Example portal dosimetry measurement for one case with arcs named CW (clockwise) and CCW (counter clockwise). The predicted
images are shown on the left (for the M120 plan), with gamma maps (4%/1 mm, local normalization) on the right. The 10% dose threshold is
outlined in red. Orange pixels indicate failing measurement points (gamma >1).
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TAB L E 4 Summary of portal dosimetry results. A passing arc is defined as a defined as an arc with a gamma pass rate of greater than 95%. A
passing plan is defined as a plan where both arcs pass. All measurements are locally normalized unless otherwise stated.
M120(HD) HD HD(MU)
Average arc pass rate 99.1  1.0
(P < 0.001 vs HD)
94.4  2.3
(P < 0.001 vs HD(MU))
95.5  2.3
(P < 0.001 vs M120(HD))
Percentage of passing arcs 94.1% 41.2% 58.8%
Percentage of passing plans 94.1% 29.4% 52.9%
Percentage of passing
plans (using global normalization)
94.1% 78.9% 85.7%
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used in the comparison of deliverability were calculated using the
same beam model and delivered using the same delivery platform.
However, because the HD and HD(MU) plans are more modulated,
they are likely to be more sensitive to any weaknesses in the beam
model or MLC parameters such as transmission and DLG.
4.C | Comparison to previous studies
Many other groups have performed planning studies to examine the
benefit of the smaller HD-MLC leaf width. Chae et al found that for
artificially contoured spine lesions, the HD-MLC significantly improved
GI but not CI, but that the results more notable for IMRT vs VMAT.
The biggest gains were seen for complex target shapes.7 Tanyi et al
performed a planning study comparing the M120 to HD-MLC for liver
and lung with 3D, IMRT, and VMAT treatment plans and found small
differences between the MLC types with the biggest difference being
the faster dose falloff with the HD-MLC.8 Dhabaan et al examined the
benefit of the HD-MLC for intracranial radiosurgery planning with
dynamic conformal arcs and found that conformity and dose gradients
were both improved with the HD-MLC.9
Though there is no question that the HD-MLC may provide a
benefit for certain body sites and certain types of target geometries,
there have been very few studies looking at the deliverability impact
of the HD-MLC. Wuu et al used CT-based polymer gel dosimetry to
show that for a 2.5 cc radiosurgery volume treated with IMRT, CI
and dose falloff were both improved with the smaller MLC..10 Kairn
et al did not use the HD-MLC but studied delivery accuracy for the
treatment of spinal metastases using portal dosimetry and radiochro-
mic film.11 They found that IMRT plans tended to be more deliver-
able than dosimetrically similar VMAT plans even though the
delivery time was longer. Similar to the present study, the authors
were able to improve delivery accuracy by limiting the MU of the
plans.
We note that one weakness of this study is that the PDIP algo-
rithm is a standalone algorithm that is configured independently of
the AAA algorithm (although it does have some shared beam data),
and therefore does not directly verify the dose calculation of AAA.12
While our clinical ArcCHECK experience appears to support the find-
ings in this work that deliverability is reduced with the HD-MLC, the
ArcCHECK is a coarse measurement compared to the target size of
most of the spine plans studied. Further analysis of these plans could
be performed using film to more thoroughly verify the AAA dose cal-
culation strengths and weaknesses.
The solution found by the optimizer for the M120 plans is part
of the solution set available for the HD and HD-MU plans, however,
the optimizer tends to choose more highly modulated plans. This is
partially a result of the fact that the optimizer does not have direct
feedback about the modulation in the plan, outside of the number of
MU, and therefore is not able to directly limit the modulation.3 The
MU objective is not a sufficient tool for ensuring the deliverability of
plans while at the same time effectively searching for an acceptable
dose distribution.
In practice when using the HD-MLC, the user will not typically
have a comparison M120 plan, so it is difficult or impossible to
effectively judge the modulation complexity versus the plan quality
to find an acceptable solution. Using a complexity metric like the
one employed here aids in comparing newly created plans to past
plans that have previously been measured for delivery accuracy.
Besides analyzing complexity postoptimization, planners need
improved tools for limiting modulation when it is not needed in
order to ensure an accurate delivery of the dose. One potential solu-
tion is to penalize complexity during the optimization in order to
help guide the optimizer into the solution space that represents an
acceptable compromise between plan quality and deliverability.3
Though in this work the HD-MLC plans exhibit modest gains in the
quality of the dose distribution, this improvement will come at a cost
in terms of calculation accuracy, delivery accuracy, and delivery effi-
ciency. Additionally, if calculation and delivery accuracy are sacri-
ficed, one cannot be sure that the promised dosimetric gains are in
fact realized.
5 | CONCLUSION
The HD-MLC theoretically allows improved dose distributions
through added degrees of optimization freedom, however, care must
be taken during the optimization process to avoid needlessly increas-
ing the level of plan modulation. We have shown that increased plan
complexity may lead to increased delivery uncertainty while at the
same only modestly improving the dosimetric quality of the plan.
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